Human LRPAP Antibody Summary
Accession # P30533
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
LRPAP in A549 Human Cell Line. LRPAP was detected in immersion fixed A549 human lung carcinoma cell line using Goat Anti-Human LRPAP Antigen Affinity-purified Polyclonal Antibody (Catalog # AF4296) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to Golgi and endoplasmic reticula. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
LRPAP (LDL receptor-related protein-associated protein 1; also named RAP), is a ubiquitously expressed 39 kDa chaperone for LDL receptor family proteins (1, 2). Mature human LRPAP shares 77% amino acid sequence identity with mouse and rat LRPAP. It is organized into three domains of comparable length. Domains D2 and D3 interact with each other, while D1 is independent (3). The D1 domain contains a low affinity binding site for LRP, and the associated D2 and D3 domains bind LRP with high affinity (4). The majority of LRPAP is localized in the endoplasmic reticulum and Golgi (5). LRPAP prevents the premature interaction of LRP, LRP2/megalin, and VLDLR with their coexpressed ligands, thereby promoting proper receptor folding and export from the ER (6‑8). Protonation of conserved histidine residues within the D3 domain induces the separation of LRPAP and LRP in the relatively acidic Golgi (9). LRPAP, which contains a C-terminal HNEL motif, can then recycle to the ER (9). A minor amount of LRPAP remains associated with LRP and can modulate receptor activity on the cell surface (5). Exogenously applied LRPAP competitively inhibits LDL receptor family binding and uptake of activated alpha 2-macroglobulin, apoB100- or apoE-enriched LDL and VLDL particles, cholesteryl esters, and complexes of PAI-1 with either tPA or uPA (10‑14).
- Strickland, D.K. et al. (1991) J. Biol. Chem. 266:13364.
- Bu, G. (2001) Int. Rev. Cytol. 209:79.
- Lazic, A. et al. (2003) Biochemistry 42:14913.
- Lazic, A. et al. (2006) Arch. Biochem. Biophys. 450:167.
- Bu, G. et al. (1994) J. Biol. Chem. 269:29874.
- Willnow, T.E. et al. (1996) EMBO J. 15:2632.
- Bu, G. and S. Rennke (1996) J. Biol. Chem. 271:22218.
- Obermoeller, L.M. et al. (1997) J. Biol. Chem. 272:10761.
- Lee, D. et al. (2006) Mol. Cell 22:423.
- Williams, S.E. et al. (1992) J. Biol. Chem. 267:9035.
- Medh, J.D. et al. (1995) J. Biol. Chem. 270:536.
- Herz, J. et al. (1991) J. Biol. Chem. 266:21232.
- Mokuno, H. et al. (1994) J. Biol. Chem. 269:13238.
- Orth, K. et al. (1992) Proc. Natl. Acad. Sci. 89:7422.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Reviews for Human LRPAP Antibody
There are currently no reviews for this product. Be the first to review Human LRPAP Antibody and earn rewards!
Have you used Human LRPAP Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image